Homotypic and heterotypic antibodies for prevention of experimental rotavirus gastroenteritis.
We investigated the abilities of homologous and heterologous antibody preparations to neutralize murine rotavirus in a mouse model of rotavirus infection. We found that incubation of virus with murine sera obtained from animals experimentally infected with the homologous epizootic diarrhea of infant mice strain of rotavirus resulted in inability of the virus to cause symptomatic disease in infant mice. Sera from nonimmune mice and mice infected or immunized with a heterotypic strain of rotavirus did not effectively neutralize virus in this system. On the other hand, neutralization was noted after incubation of virus with a number of immunoglobulins from other animal and human sources. The neutralizing activity of the preparations in the murine model correlated partially, but not completely, with the level of in vitro neutralizing antibody to the murine strain of rotavirus measured in a tissue culture system. In most cases, asymptomatic infection after feeding of the virus and the antibody preparation resulted in subsequent generation of an active immune response in infected animals.
D000818:Animals; D000831:Animals, Newborn; D000910:Antibodies, Heterophile / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D003967:Diarrhea / Q000517:prevention & control; D005759:Gastroenteritis / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007110:Immunity, Active; D007116:Immunization, Passive; D051379:Mice; D009500:Neutralization Tests; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000276:immunology / Q000517:prevention & control*
D000910:Antibodies, Heterophile; D000914:Antibodies, Viral